Poland· PL-100284419
Ampres
A chloroprocaine product containing chloroprocaini hydrochloridum, registered in Poland by B. Braun Melsungen AG. The same ATC class is registered in 12 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Chloroprocaine is registered in 12 of 19 countries.
Countries holding a registration under ATC N01BA04 (chloroprocaine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Chloroprocaine · ATC N01BA04
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
URPL (Poland)- Active substance
- Chloroprocaini hydrochloridum
- Manufacturer
- B. Braun Melsungen AG
- Country
- Poland (PL)
- ATC code
- N01BA04
- ATC class
- Chloroprocaine
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991001681
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
24 interactions on record for chloroprocaine.
Graded by severity as the source publishes them — 23 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Chloroprocaine · interactions on record
24 records
- 23 moderate
- 1 minor
Most severe, free to view
- LidocainA01AE01moderate
- TetracainA01AE02moderate
- SulfasalazineA07EC01moderate
- LidocaineC05AD01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Chloroprocaine in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandAmpres 10 mg/ml, soluzione iniettabileSintetica SA
- SpainAMPRES 10 MG/ML SOLUCION INYECTABLEB Braun Medical S.A.
- FinlandAmpresB. Braun Melsungen AG
- FranceCLOROTEKAL 10 mg/ml, solution injectableNORDIC GROUP (PAYS-BAS)
- IrelandAmpres 10mg/ml solution for injectionB. Braun Melsungen AG
- NorwayAmpresB. Braun Melsungen AG
- BelgiumAmpres 10 mg/mlNordic Group
- SwedenAmpres 10 mg/ml Injektionsvätska, lösningB. Braun Melsungen AG
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Austria · Ampres, Visiclor
- Belgium · Ampres
- Bulgaria · Ампрес
- Germany · Ampres, Decelex
- Denmark · Ampres
- Estonia · Clorotekal
- Spain · Ampres
- Finland · Ampres
- France · Clorotekal
- United Kingdom (Northern Ireland) · Ampres
- Greece · Ampres
- Croatia · Clorotekal
- Hungary · Clorotekal
- Italy · Decelex
- Luxembourg · Ampres
- Latvia · Clorotekal
- Netherlands · Ampres
- Norway · Ampres
- Portugal · Ampres
- Sweden · Ampres
- Slovenia · Decelex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fd3b9af8-4374-482a-b475-466f5de33429 GET /v1/drugs/fd3b9af8-4374-482a-b475-466f5de33429?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "10 mg/ml",
"packaging": "05909991001681 ¦ Rp ¦ 78689\n10 amp. 5 ml",
"substance": "Chloroprocaini hydrochloridum 10 mg/ml",
"common_name": "Chloroprocaini hydrochloridum",
"pl_product_id": "100284419",
"pozwolenie_nr": "20472",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about chloroprocaine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.